Inhibitory activity and conformational transition of alpha 1-proteinase inhibitor variants. |
| |
Authors: | A J Schulze R Huber E Degryse D Speck R Bischoff |
| |
Institution: | Max-Planck-Institut für Biochemie, Martinsried, Federal Republic of Germany. |
| |
Abstract: | Several variants of alpha 1-proteinase inhibitor (alpha 1-PI) were investigated by spectroscopic methods and characterized according to their inhibitory activity. Replacement of Thr345 (P14) with Arg in alpha 1-PI containing an Arg residue in position 358 (yielding Thr345----Arg, Met358----Arg]alpha 1-PI) results in complete loss of its inhibitory activity against human alpha-thrombin; whereas an exchange of residue Met351 (P8) by Glu ( Met351----Glu, Met358----Arg]alpha 1-PI) does not alter activity. Thr345----Arg, Met358----Arg]alpha 1-PI is rapidly cleaved by thrombin, while Met358----Arg]alpha 1-PI and Met351----Glu, Met358----Arg]alpha 1-PI form stable proteinase-inhibitor complexes. The stability of Thr345----Arg, Met358----Arg]alpha 1-PI against guanidinium chloride denaturation is significantly enhanced compared to wild-type alpha 1-PI, and does not change after cleavage, resembling ovalbumin, a serpin with no inhibitory activity, from which the Thr345----Arg amino acid exchange had been derived. Met351----Glu, Met358----Arg]alpha 1-PI and Met358----Arg]alpha 1-PI resemble the wild-type protein in this respect. The CD spectra of intact and cleaved alpha 1-PI variants do not compare well with the wild-type protein, probably reflecting local structural differences. Insertion of a synthetic peptide, which corresponds to residues Thr345----Met358 of human alpha 1-PI, leads to the formation of binary complexes with all variants having the characteristic features of the binary complex between peptide and wild-type protein. |
| |
Keywords: | |
|
|